RT Journal Article
SR Electronic
T1 Relapses and subsequent worsening of disability in relapsing-remitting multiple sclerosis
JF Neurology
JO Neurology
FD Lippincott Williams & Wilkins
SP 804
OP 808
DO 10.1212/01.wnl.0000234064.17156.03
VO 67
IS 5
A1 Young, P. J.
A1 Lederer, C.
A1 Eder, K.
A1 Daumer, M.
A1 Neiss, A.
A1 Polman, C.
A1 Kappos, L.
A1 ,
YR 2006
UL http://n.neurology.org/content/67/5/804.abstract
AB Objective: To investigate whether relapses contribute to the development of subsequent sustained increase of impairment and disability in patients with multiple sclerosis (MS). Methods: In a random sampled subset of 256 relapsing-remitting MS (RRMS) patients from the placebo arms of 20 randomized, controlled clinical trials contained in the Sylvia Lawry Centre for MS Research (SLCMSR) open database (mean follow-up time 2.66 years), the authors tested whether time to an increase of the Expanded Disability Status Scale (EDSS) score (confirmed after 6 months) was related to the occurrence of prior relapses. In the primary analysis, EDSS progressions starting within the period used to calculate the on-study relapse rate (sacrifice period) were not counted. The result obtained was then validated in an independent validation part of the SLCMSR database (n = 320). Results: Although in the first subset of 256 RRMS patients, occurrence of relapses in the first 4 months on study appeared to be the best predictor for a shorter time to subsequent sustained increase in the EDSS score (hazard ratio [HR] 2.26 [95% CI: 1.36 to 3.75]), this finding was not confirmed in the validation dataset (HR 1.35, one-sided Wald test, lower limit of the 95% CI: 0.90). Conclusion: Although relapses may result into permanent damage and Expanded Disability Status Scale (EDSS) progression, there is no consistent effect of on-study relapses on the subsequent development of sustained EDSS score increase during a typical clinical study observation period.